Defence Therapeutics Inc. (CSE:DTC)

Defence Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	1.23	0.06	2.79	0.51	5.45
Cash & Short-Term Investments	1.23	0.06	2.79	0.51	5.45
Cash Growth	2079.47%	-97.97%	451.20%	-90.71%	192.24%
Other Receivables	0.2	0.1	0.15	0.03	0.07
Receivables	0.2	0.1	0.15	0.03	0.07
Prepaid Expenses	0.03	0.06	0.49	0.14	0.04
Total Current Assets	1.46	0.21	3.43	0.67	5.56
Property, Plant & Equipment	0.19	0.26	0.06	-	-
Other Intangible Assets	-	-	0.04	0.05	0.05
Total Assets	1.65	0.48	3.53	0.72	5.61
Accounts Payable	1.4	2.09	0.19	0.98	0.11
Short-Term Debt	-	0.05	-	-	-
Current Portion of Long-Term Debt	1.49	1.66	-	-	-
Current Portion of Leases	0.02	0.03	-	-	-
Other Current Liabilities	-	0.22	0.03	0.13	0.01
Total Current Liabilities	2.91	4.05	0.22	1.11	0.12
Long-Term Debt	-	-	1.75	-	-
Long-Term Leases	-	0.01	-	-	-
Total Liabilities	2.91	4.06	1.97	1.11	0.12
Common Stock	24.19	19.24	16.95	9.33	7.97
Retained Earnings	-29.31	-29.81	-16.91	-10.52	-3.53
Comprehensive Income & Other	3.86	6.98	1.52	0.79	1.05
Shareholders' Equity	-1.26	-3.58	1.57	-0.39	5.49
Total Liabilities & Equity	1.65	0.48	3.53	0.72	5.61
Total Debt	1.5	1.75	1.75	-	-
Net Cash (Debt)	-0.27	-1.69	1.05	0.51	5.45
Net Cash Growth	-	-	106.61%	-90.71%	192.24%
Net Cash Per Share	-0.01	-0.04	0.03	0.01	0.21
Filing Date Shares Outstanding	54.71	45.54	44.27	37.68	35.96
Total Common Shares Outstanding	54.71	45.54	43.78	36.63	35.22
Working Capital	-1.44	-3.84	3.21	-0.43	5.44
Book Value Per Share	-0.02	-0.08	0.04	-0.01	0.16
Tangible Book Value	-1.26	-3.58	1.53	-0.43	5.44
Tangible Book Value Per Share	-0.02	-0.08	0.03	-0.01	0.15
Machinery	-	0.27	0.07	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.